Dysfunction : Actualité Dysfunction en direct - P1 | Bourse Reflex
Accueil > Tags > Dysfunction

  • Toutes les actualités en rapport avec « Dysfunction »

19/10 16:35 Dysfunction - Apricus Biosciences Announces Issuance of Korean Patent, Expanding Its Patent Portfolio for Its Topical Cream to Treat Premature Ejaculation

14/10 08:30 Dysfunction - Apricus Biosciences Announces New Data Published in the International Journal of Pharmaceutics Confirming Efficiency of NexACT(R) Drug Delivery Technology

06/10 16:05 Dysfunction - Apricus Biosciences to Present Poster of Femprox(R) Phase III Clinical Data at Upcoming Industry Conference

03/10 20:05 Dysfunction - Apricus Biosciences Announces Korean Patent Approval for MycoVa(TM) for Nail Fungus

12/09 08:15 Dysfunction - Apricus Biosciences to Provide Overview of Rx and Consumer Healthcare Divisions at the 11th Annual Biotech in Europe Investor Forum

31/08 16:20 Dysfunction - Apricus Biosciences Receives FDA Clearance for Its Third OTC Drug Containing NexACT(R) Technology

18/08 15:00 Dysfunction - Photo Release -- Apricus Biosciences Announces FDA Clearance for Its First Anti-Fungal OTC Drug (Tolnaftate-D(TM)) Containing NexACT(R) Technology

12/08 09:00 Dysfunction - Apricus Biosciences Announces Second Quarter 2011 Financial Results Conference Call

08/08 16:05 Dysfunction - Apricus Biosciences to File for Market Authorization to Sell Vitaros(R) for Erectile Dysfunction in Latin America

05/08 09:00 Dysfunction - Apricus Biosciences Provides Corporate Mid-Year Update

19/07 16:00 Dysfunction - Apricus Biosciences Files Marketing Application for Vitaros(R) as a Treatment for Erectile Dysfunction in Switzerland

28/06 18:50 Dysfunction - Apricus Biosciences' Marketing Application for Vitaros(R), for the Treatment of Erectile Dysfunction, is Accepted for Review in Europe

27/06 16:00 Dysfunction - Apricus Biosciences Reports Reanalysis of Its U.S. Phase III Trials for MycoVa(TM) Showing Drug is Effective in Mycological Cure Resulting in Eradication of Nail Fungus

20/06 08:35 Dysfunction - Apricus Biosciences' CEO Sees Higher Revenue if Pfizer Viagra(R) Litigation is Successful

03/06 15:00 Dysfunction - Apricus Biosciences Appoints Steve Martin as Senior Vice President and Chief Financial Officer

03/06 14:00 Dysfunction - Apricus Bio CEO to Present Commercialization Plans for Vitaros(R) at Jefferies 2011 Global Healthcare Conference

31/05 16:50 Dysfunction - Apricus Biosciences Announces Issuance of Key Patent for RayVa(TM) for Raynaud's Phenomenon in Israel

27/05 11:00 Dysfunction - Apricus Biosciences' CEO to Present at Jefferies 2011 Global Healthcare Conference

24/05 08:55 Dysfunction - Apricus Biosciences to Present at the Euro-Biotech Partnering Forum 2011 to Further Its Partnership Efforts

20/05 16:10 Dysfunction - Apricus Biosciences Will Request Approval of Vitaros(R) as a Treatment for Erectile Dysfunction in Switzerland, Based on Guidance From Swiss Regulatory Authorities